Elucid AI-PREDICT study begins testing lesion-level heart attack risk with CCTA
Elucid’s AI-PREDICT study will test whether CCTA plaque analysis can identify the coronary lesions most likely to cause a heart attack.
Medical Devices & Diagnostics
Medical Devices & Diagnostics
HeartBeam’s peer-reviewed ECG data raises the stakes in remote cardiac diagnostics
HeartBeam’s ECG evidence could push chest pain assessment closer to patients. The next test is FDA clarity and clinical trust.